Final Flashcards

1
Q

Abnormal amounts of lipids in the blood, elevated cholesterol, triglycerides, LDL-C or low HDL-C; caused by poor lifestyle choices/diet, genetics; 30% of US pop. has this. Symptoms include weight gain, fatigue, depression, loose stools, bumps on skin, & heart pain

A

Dyslipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Internal pressure on the arteries by the blood, leads to left ventricular hypertrophy; lifestyle factors - diet, alcohol, overweight/obese, stress, sedentary behavior. Known as the SILENT KILLER, symptoms may not be present

A

Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4th Leading cause of death in US; inflamed airways due to exposure to polluted air, damage to airways and alveoli. Symptoms include dyspnea, chronic cough, sputum production, & chest sounds

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Abnormal growth of tissue (neoplasm), unregulated cellular proliferation, usually forms a distinct mass, may spread to other parts of the body; can originate in any organ system. 33% of diagnoses are associated with cigarette smoking, another 33% due to alcohol, sex practices, pollution, diet.

A

Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Progressive degenerative joint disease from aging, overuse, injury

A

Osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Autoimmune disease, chronic/systemic attack on joint lining damaging articular cartilage and ligaments

A

Rheumatoid Arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2nd most common neurodegenerative disease; brain cells that produce neurotransmitters (dopamine, serotonin, norepinephrine) die

A

Parkinson Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Autoimmune disease, inflammatory damage to myeline sheaths

A

Multiple Sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Serotonin, dopamine, and norepinephrine dysregulation, interferes w social, occupational aspects, Ex reduces symptoms

A

Anxiety & Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Positive energy balance, BMI above 25, above 30, 32% of children and 70% of adults in the US

A

Overweight/Obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Caused by lifestyle, “adult onset,” positive energy balance, sedentary behavior, insulin resistance, insufficient insulin production

A

Type II Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Autoimmune attack on the Beta cells of the pancreas, childhood onset, symptoms of thirst, visual disruptions, requires insulin for life

A

Type I Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Damage to vessels typically in the legs, signified by claudication/cramping/pain in the extremities

A

PAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Replacement of the organ, no longer innervated by the nervous system, Symptoms include elevated RHR, blunted Ex HR, Elevated BP @ rest, blunted BP w EX

A

Heart Transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Used to regulate HR when too slow as well as to synchronize the chambers, symptoms include fatigue and dyspnea

A

Pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inability to effectively pump blood to the body, symptoms include fatigue and dyspnea

A

Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ex Testing Considerations for HF

A

Lower peak HR, SV, and Q; large vessels don’t dilate well, Ex tolerance is reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ex Testing Considerations for Pacemaker

A

Evaluate HR and rhythm responses, maintain a HR below threshold for defibrillation, avoid upper extremity vigorous Ex for 3-4 wks (implantation incision needs to heal), perform light upper ROM to reduce joint complications

19
Q

Ex Testing Considerations for Heart Transplant

A

Peak Q is reduced by 20-35%; RHR is elevated, HR response to Ex; increase in HR relies on catecholamines, thus delayed Ex response; BP elevated @ rest and blunted during Ex

20
Q

Ex Testing Considerations for Overweight/Obese

A

Testing not necessary w low/moderate Ex program if no chronic issues, timing of medications, musculoskeletal or orthopedic conditions

21
Q

Ex Testing Considerations for Anxiety/Depression

A

If struggling w Ex, begin w flexibility on the floor/ground, focus on breathing, stretching, posture

22
Q

Ex Testing Considerations for Multiple Sclerosis

A

Test early in the day, climate controlled room, RPE and HR, 6-min WT, Time Up-Go, surveys (MS impact scale)

23
Q

Ex Testing Considerations for Parkinson Disease

A

Assess CVD risk; balance, gait, ROM, cycle ergometry, RPE scale, Time Up-Go, 6-min WT, MMT

24
Q

Ex Testing Considerations for Arthritis

A

Use testing methods that don’t worsen pain; do not test during acute inflammation; include a warm-up; monitor pain via scales

25
Q

Ex Testing Considerations for Cancer

A

Monitor for effects of treatment (i.e. fatigue, nausea, anemia, dizziness; have clients fill out a PAR-Q, no testing for walking or flexibility Rx, screen for co-morbidities; biomechanical assessment for gait, standing, COD

26
Q

Ex Testing Considerations for COPD

A

Treadmill, cycle, 6-min WT; quantify Ex capacity to establish baseline; graded test should last no longer than 8-12 min; check oxyhemoglobin desaturation during test; use Borg 1-10 and Dyspnea 1-4 scales

27
Q

Ex Testing Considerations for Hypertension

A

Take usual meds for testing, may be on beta blockers, if hypertension is uncontrolled - consult w physician; stage 2 SBP > 160 or DBP > 100 - no Ex until physician eval; HR response w beta blockers will be blunted

28
Q

Ex Testing Considerations for Dyslipidemia

A

No testing necessary for asymptomatic individuals; underlying CVD may be present; statins may cause muscle myalgia and fatigue

29
Q

Prescription Considerations for Inpatient CVD

A

No new chest pain; stable or falling CK levels and troponin values; no resting dyspnea; normal cardiac rhythm and stable ECG for 8 hrs; Discontinue Ex if DBP over 110, SBP drops w ^ Int., arrhythmias, heart block, dyspnea, angina, or ECG changes indicating ischemia

30
Q

Prescription Considerations for Outpatient CVD

A

Warm-up and Cool-down; upper and lower conditioning; monitor for angina and stop if induced w/ Ex; use RPE for intensity; take meds normally; use small bouts to accumulate time

31
Q

Prescription Considerations for Heart Failure

A

Main goals should be reversing Ex intolerance and decreasing the risk of a cardiac event; gradually increase volume

32
Q

Prescription Considerations for Type II Diabetes

A

Short, high intensity Ex reduced the decline of blood glucose, address comorbidities, Ex every 48 hrs, RT is as effective as CR, perform RT before CR to reduce hypoglycemia, collagen glycation in joints

33
Q

Prescription Considerations for Overweight/Obese

A

Goal of 3-10% body mass loss over 3-6 mo., reduce EI 500-1000 kcal/day, medical supervision if goal loss exceeds 10%

34
Q

Prescription Considerations for Multiple Sclerosis

A

Monitor signs of fatigue (OMNI scale), heat intolerance, balance issues, vision issues, requests/needs for longer rest periods, Ex helps w depression;

35
Q

Prescription Considerations for Parkinson Disease

A

Bradykinesia, Akinesia, Dyskinesia (slow, no, or uncoordinated movement); Neuromotor training should be incorporated to improve balance, coordination, gait, etc. (i.e. yoga, tai-chi, stability ball training)

36
Q

Prescription Considerations for Arthritis

A

Gradual progression of Int. and volume; modify as needed for pain and functional limitation; warm-up and cool down to minimize pain; accumulate smaller bouts if needed; RT may reduce chronic pain due to muscular support of joints; flexibility may improve ROM and maintain mobility; Pool Ex may be helpful as may functional training (sit-stand, etc.); reminders that discomfort is normal; neuromotor Ex may be helpful (yoga, tai-chi, pilates)

37
Q

Prescription Considerations for Cancer

A

Consider tumor site, healing, tenderness; cancer-specific Ex depending on type, treatment, status of cancer, extremity damage, lymphedema, and ROM issues

38
Q

Prescription Considerations for COPD

A

More intensity may increase benefits; have an inhaler nearby; RT may help w muscle functions and ADLs

39
Q

Prescription Considerations for Hypertension

A

Ex will lead to BP reduction of 5-7 mmHg, decrease in heart wall thickness and left ventricular thickness

40
Q

Prescription Considerations for Dyslipidemia

A

Modify Ex Rx for comorbidities; use RPE scale; can accumulate bouts; refer to elderly FITT chart for individuals >65 yrs.

41
Q

Type II Diabetes HbA1C & Blood Glucose Levels

A

> 5.7% HbA1C, >100 Blood Glucose

42
Q

BMI Classifications

A

<18.5 - Underweight
18.5-24.9 - Normal
25.0-29.9 - Overweight
30.0-34.9 - Obese I
35.0-39.9 - Obese II
>40.0 - Obese III

43
Q

BP Classifications

A

Normal - <120 and <80
Elevated - 120-129 and <80
Stage 1 - 130-139 and/or 80-89
Stage 2 - >140 and/or >90